Baxano Surgical Company Profile (NASDAQ:BAXS)

About Baxano Surgical

Baxano Surgical logoBaxano Surgical, Inc., formerly Baxano Inc. is a medical device company. The Company is focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. The Company markets the AxiaLIF pre-sacral access and interbody fusion system for single and two level lower lumbar fusion, the VEO lateral access and interbody fusion system, the iO-Flex set of flexible instruments used by surgeons during spinal decompression procedures, and the iO-Tome instrument for rapid and precise removal of bone, specifically the facet joints, a technique which is commonly performed in spinal fusion procedures. The Company's other products include: Vectre facet screw system, Bi-Ostetic bone void filler, bowel retractors, discectomy tools, and a bone graft harvesting system that can be used to extract bone graft from the patient's hip for use in fusion procedures.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BAXS
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $N/A
  • 200 Day Moving Average: $N/A
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.06
  • P/E Growth: N/A
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for Baxano Surgical (NASDAQ:BAXS) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Baxano Surgical (NASDAQ:BAXS)
DateFirmActionRatingPrice TargetDetails
11/13/2014Summer StreetDowngradeBuy -> SellView Rating Details
(Data available from 10/24/2014 forward)


Earnings History for Baxano Surgical (NASDAQ:BAXS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/5/2014($0.14)($0.18)ViewN/AView Earnings Details
5/8/2014($0.12)($0.19)ViewN/AView Earnings Details
3/6/2014($0.14)($0.19)ViewN/AView Earnings Details
8/8/2013Q2 2013($0.14)($0.21)$6.90 million$3.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Baxano Surgical (NASDAQ:BAXS)
Current Year EPS Consensus Estimate: $-0.5700 EPS
Next Year EPS Consensus Estimate: $-0.4000 EPS


Dividend History for Baxano Surgical (NASDAQ:BAXS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Baxano Surgical (NASDAQ:BAXS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2014Kenneth Michael RealiCEOBuy10,000$0.38$3,800.00View SEC Filing  
5/12/2014Kenneth Michael RealiCEOBuy7,050$0.71$5,005.50View SEC Filing  
12/5/2013Kenneth Michael RealiCEOBuy10,500$1.11$11,655.00View SEC Filing  
5/31/2013Roderick A YoungDirectorBuy1,340,034$2.28$3,055,277.52View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Baxano Surgical (NASDAQ:BAXS)
News IconBaxano Surgical streamlines its business operations (NASDAQ:BAXS) - September 19 at 4:40 PM


Baxano Surgical (NASDAQ:BAXS) Chart for Monday, October, 24, 2016

Last Updated on 10/24/2016 by Staff